Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim ...

Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...

In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...

Sponsor logos have been commonly found on one of the playing surfaces at the Kohl Center for years. They're a new addition to the other one. The basketball court now has Culver's logos on two spots ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...